No insider purchase over the last 90 days. The latest was filed 07 Aug 2024.
Atomera Inc, classified in the Chemicals & Materials sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). Over the twelve months to 18 October 2026, 76 filings were filed, from 8 insiders.
The flow runs one way only: 54 sales worth €371k, from 3 insiders, and no purchase. No amount is published for 13 filings, which the totals therefore leave out. Biggest ticket of the year: €45k, sold by Bibaud Scott A. and made public on 2 June 2026 (0.029% of market cap).
Compared with its exchange (5,458 companies, median 22 filings), a count of 76 filings is above the norm. Since 2021, the database holds 5 purchases and 134 sales by insiders of the company. The 10-K for the year ended 31 December 2025 shows 65,000 USD of revenue and -20.2 m USD of net income.
The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
Elsewhere in the same sector, our signals recently picked up insider purchases at Culp Inc and Gold.com, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2025 · cache
25 of 203 declarations
Atomera Inc. is a United States-based company listed on the NASDAQ market, focused on semiconductor materials and intellectual property licensing rather than chip manufacturing. Founded in 2001 by Robert Mears, the company originally operated under the name Mears Technologies before changing its name to Atomera in 2016, the same year it completed its initial public offering on NASDAQ. Its headquarters are in Los Gatos, California, placing it within one of the world’s most important technology hubs.
Atomera’s business model is built around its proprietary Mears Silicon Technology™ (MST®), a quantum-engineered material designed to improve transistor performance in silicon-based devices. According to the company, MST can enhance speed, power efficiency and variability control while fitting into existing semiconductor manufacturing flows with limited process disruption. In practical terms, Atomera is aiming to help customers extract more performance from current fabs and process nodes, rather than competing as a wafer producer or integrated device manufacturer.
This makes Atomera a niche technology licensing company with a capital-light profile, but also with a commercial ramp that depends on customer qualification cycles in a highly demanding industry. The company’s value proposition rests on patents, materials science know-how, and the ability to solve performance and power challenges for semiconductor makers seeking incremental but meaningful gains. Atomera’s model typically involves staged customer engagement: evaluation, integration, and eventually manufacturing-scale licensing if the technology is adopted in production.
Its key offerings are centered on MST and related design and simulation tools such as MSTcad™, which are intended to support adoption across applications including mobile devices, IoT, infrastructure, logic, memory, analog and power devices, RF products, and image sensors. Atomera is headquartered in the United States, but its commercial opportunity is global, targeting semiconductor foundries, IDM customers and fabless chip companies across major technology markets.
Recent developments in 2025 and 2026 have highlighted both technical progress and ongoing commercialization efforts. The company has discussed customer engagement, strategic collaborations and work related to GaN-on-silicon applications, signaling that MST is being positioned for next-generation power, communications and advanced electronics use cases. At the same time, Atomera remains an early-stage commercialization story, with limited revenue scale and a profile that is still dependent on converting technical validation into broader industrial deployment. For investors, that combination creates a high-risk, high-upside exposure to semiconductor materials innovation.
Purchases our model currently ranks for the recommendations list.
All recommendations| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2025 | 65,000 USD | -20.2 m USD | -0.65 USD | 10-K |
| Dec 2024 | 135,000 USD | -18.4 m USD | -0.68 USD | 10-K |
| Dec 2023 | 550,000 USD | -19.8 m USD | -0.80 USD | 10-K |
| Dec 2022 | 382,000 USD | -17.4 m USD | -0.75 USD | 10-K |
| Dec 2021 | 400,000 USD | -15.7 m USD | -0.70 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.